• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-016
Medical Device Problem Codes Difficult to Fold, Unfold or Collapse (1254); Patient-Device Incompatibility (2682)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/31/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2022, a 16mm amplatzer septal occluder was chosen for implant.During the procedure, it was reported that the device was not able to deploy well and was not fully released from the delivery system.It was decided that the product would be replaced using a 18mm non-abbott occluder.There was no clinically significant delay in procedure and no adverse patient effects.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of the device not being able to deploy well was reported.Device deformation did not occur, but the cardiac structures had interaction with the device.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the device went too deep into the rim of the aorta and that the device was not meant to make contact.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.H6: device code 1254 was removed.
 
Event or Problem Description
Subsequent to the initially filed report, the following information was received: an 8f amplatzer trevisio intravascular delivery system was used to deliver the device.There was no noticed angulation or kinks in the delivery system.When attempting to implant the device, the right atrium disk went deeper than anticipated and interacted with the rim of the aorta.There was no resistance noted when attempting to implant the device.No deformation was reported.The replacement device did not make contact with the aorta.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15497261
Report Number2135147-2022-01394
Device Sequence Number12218549
Product Code MLV
UDI-Device Identifier05415067019240
UDI-Public05415067019240
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2024
Device Model Number9-ASD-016
Device Catalogue Number9-ASD-016
Device Lot Number6868112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/31/2022
Supplement Date Received by Manufacturer12/02/2022
Initial Report FDA Received Date09/28/2022
Supplement Report FDA Received Date12/05/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/20/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTEM
Patient SexUnknown
-
-